Types of Preimplantation Genetic Testing
IVFMD offers the following pre-implantation genetic tests for embryos.
Preimplantation Genetic Testing for Monogenic / Single Gene Defects (PGT-M)
Formerly known as preimplantation genetic diagnosis (PGD), PGT-M is a procedure that screens for and detects the presence of genes for specific diseases, such as Cystic Fibrosis, Spinal Muscular Atrophy, Sickle Cell Disease, Tay-Sachs, and other genetic diseases in embryos. This test is especially important when one or both parents have a known genetic disease or are carriers of a genetic disease. Prior to implantation, the embryos are analyzed so that only unaffected embryos are transferred.
Preimplantation Genetic Testing for Aneuploidy (PGT-A)
Formerly known as preimplantation genetic screening (PGS), PGT-A is when embryos are examined to determine if they have a normal number of chromosomes (which should be 46). The PGT-A technique allows our laboratory to select embryos that have the highest chance of having the correct number of chromosomes. There is preliminary evidence to suggest that aneuploidy screening (screening embryos for the normal number of chromosomes) in certain couples may improve their odds of a having successful pregnancy with IVF since:
- Embryos selected have an improved potential for implantation, increasing the likelihood of pregnancy.
- Chosen embryos have a decreased rate of spontaneous loss, lessening the chances of miscarriage.
- The chances of having a baby with chromosomal abnormalities are greatly reduced.
The PGT Process
In both PGT-M and PGT-AS, a micromanipulator and laser are used to remove a small sample of cells for analysis. Unlike prior methods of genetic testing, ALL chromosomes are analyzed (older technologies only examined a handful). Embryos that are free of selected genetic diseases or that possess the normal number of chromosomes can be selected for subsequent transfer.